Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepri

Showing results (641-650 of 959) with videos related to

Pageof 96
Sort By:
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohortFabio Vescini, Alessandro Cozzi-Lepri, Marco Borderi, et al.
International Journal of Antimicrobial Agents|September 12, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?A Vergori, R Gagliardini, N Gianotti, et al.
The Journal of ECT|January 20, 2026
Electroconvulsive Therapy for Behavioral, Mood, and Catatonic Symptoms in Patients With Frontotemporal Dementia: A Literature ReviewCamilla Elefante, Chiara Fustini, Vittoria Lepri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2026
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIVPaola Saltini, Alessandro Cozzi-Lepri, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life settingAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonio Di Biagio, et al.
European Journal of Medical Genetics|November 23, 2020
Recurrent prenatal PIEZO1-related lymphatic dysplasia: Expanding molecular and ultrasound findingsGioia Mastromoro, Daniele Guadagnolo, Antonella Giancotti, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Rheumatology and Immunology Research|December 5, 2022
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center ExperienceLaura Cometi, Cosimo Bruni, Saverio Passavanti, et al.
Pageof 96

Showing results (641-650 of 959) with videos related to

Sort By:
Pageof 96
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohortFabio Vescini, Alessandro Cozzi-Lepri, Marco Borderi, et al.
International Journal of Antimicrobial Agents|September 12, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?A Vergori, R Gagliardini, N Gianotti, et al.
The Journal of ECT|January 20, 2026
Electroconvulsive Therapy for Behavioral, Mood, and Catatonic Symptoms in Patients With Frontotemporal Dementia: A Literature ReviewCamilla Elefante, Chiara Fustini, Vittoria Lepri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2026
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIVPaola Saltini, Alessandro Cozzi-Lepri, Giorgio Bozzi, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life settingAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonio Di Biagio, et al.
European Journal of Medical Genetics|November 23, 2020
Recurrent prenatal PIEZO1-related lymphatic dysplasia: Expanding molecular and ultrasound findingsGioia Mastromoro, Daniele Guadagnolo, Antonella Giancotti, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Rheumatology and Immunology Research|December 5, 2022
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center ExperienceLaura Cometi, Cosimo Bruni, Saverio Passavanti, et al.
Pageof 96